Nisin and nisin-loaded nanoparticles: a cytotoxicity investigation

References

• WHO. Caner Geneva: World Health Organization; 2021. [cited 2021 15 July]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
   Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Kaur S, Kaur S. Bacteriocins as potential anticancer agents. Front Pharmacol. 2015;6:272.
   PubMed Web of Science ®Google Scholar
• Khazaei Monfared Y, Mahmoudian M, Cecone C, et al. Stabilization and anticancer enhancing activity of the peptide nisin by cyclodextrin-based nanosponges against colon and breast cancer cells. Polymers. 2022;14(3):594.
   PubMed Web of Science ®Google Scholar
• Chandrasekar V, Coupland JN, Anantheswaran RC. Characterization of nisin containing chitosan-alginate microparticles. Food Hydrocolloid. 2017;69:301–307.
   Web of Science ®Google Scholar
• Brötz H, Sahl H-G. New insights into the mechanism of action of lantibiotics—diverse biological effects by binding to the same molecular target. J Antimicrob Chemother. 2000;46(1):1–6.
   PubMed Web of Science ®Google Scholar
• USFDA. Microorganisms & Microbial-Derived Ingredients Used in Food (Partial List) Silver Spring: U. S. Food & Drug Administration; 2018. [cited 2020 02 January]. Available from: https://www.fda.gov/food/generally-recognized-safe-gras/microorganisms-microbial-derived-ingredients-used-food-partial-list.
   Google Scholar
• Rana K, Kumar Pandey S, Chauhan S, et al. Anticancer therapeutic potential of 5-fluorouracil and nisin co-loaded chitosan coated silver nanoparticles against murine skin cancer. Int J Pharm. 2022; 620:121744.
   PubMed Web of Science ®Google Scholar
• Patil SM, Kunda NK. Nisin ZP, an antimicrobial peptide, induces cell death and inhibits Non-Small cell lung cancer (NSCLC) progression in vitro in 2D and 3D cell culture. Pharm Res. 2022. doi:10.1007/s11095-022-03220-2
   PubMed Web of Science ®Google Scholar
• Schweizer F. Cationic amphiphilic peptides with cancer-selective toxicity. Eur J Pharmacol. 2009;625(1-3):190–194.
   PubMed Web of Science ®Google Scholar
• Gao FH, Abee T, Konings WN. Mechanism of action of the peptide antibiotic nisin in liposomes and cytochrome c oxidase-containing proteoliposomes. Appl Environ Microbiol. 1991;57(8):2164–2170.
   PubMed Web of Science ®Google Scholar
• Moll GN, Clark J, Chan WC, et al. Role of transmembrane pH gradient and membrane binding in nisin pore formation. J Bacteriol. 1997;179(1):135–140.
   PubMed Web of Science ®Google Scholar
• Mohammadi P, Zangeneh M, Mohammadi-Motlagh H-R, et al. The antimicrobial peptide, nisin, synergistically enhances the cytotoxic and apoptotic effects of rituximab treatment on human Burkitt's lymphoma cell lines. Rep Biochem Mol Biol. 2020;9(3):250–256.
   PubMed Web of Science ®Google Scholar
• Prince A, Tiwari A, Ror P, et al. Attenuation of neuroblastoma cell growth by nisin is mediated by modulation of phase behavior and enhanced cell membrane fluidity. Phys Chem Chem Phys. 2019;21(4):1980–1987.
   PubMed Web of Science ®Google Scholar
• Joo NE, Ritchie K, Kamarajan P, et al. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC 1. Cancer Med. 2012;1(3):295–305.
   PubMed Web of Science ®Google Scholar
• Hosseini SS, Hajikhani B, Faghihloo E, et al. Increased expression of caspase genes in colorectal cancer cell line by nisin [research article]. Arch Clin Infect Dis. 2020;15(2):e97734.
   Web of Science ®Google Scholar
• Jain SK, Haider T, Kumar A, et al. Lectin-Conjugated clarithromycin and acetohydroxamic Acid-Loaded PLGA nanoparticles: a novel approach for effective treatment of H. pylori. AAPS PharmSciTech. 2016;17(5):1131–1140.
   PubMed Web of Science ®Google Scholar
• Haider T, Tiwari R, Vyas SP, et al. Molecular determinants as therapeutic targets in cancer chemotherapy: an update. Pharmacol Ther. 2019;200:85–109.
   PubMed Web of Science ®Google Scholar
• Tiwari R, Jain P, Asati S, et al. State-of-art based approaches for anticancer drug-targeting to nucleus. J Drug Deliv Sci Technol. 2018;48:383–392.
   Web of Science ®Google Scholar
• Hoda M, Pajaniradje S, Shakya G, et al. Anti-proliferative and apoptosis-triggering potential of disulfiram and disulfiram-loaded polysorbate 80-stabilized PLGA nanoparticles on hepatocellular carcinoma Hep3B cell line. Nanomedicine. 2016;12(6):1641–1650.
   PubMed Web of Science ®Google Scholar
• Patra S, Mukherjee S, Barui AK, et al. Green synthesis, characterization of gold and silver nanoparticles and their potential application for cancer therapeutics. Mater Sci Eng C Mater Biol Appl. 2015;53:298–309.
   PubMed Web of Science ®Google Scholar
• Pandey V, Haider T, Chandak AR, et al. Surface modified silk fibroin nanoparticles for improved delivery of doxorubicin: development, characterization, in-vitro studies. Int J Biol Macromol. 2020; 164:2018–2027.
   PubMed Web of Science ®Google Scholar
• Haider T, Pandey V, Behera C, et al. Spectrin conjugated PLGA nanoparticles for potential membrane phospholipid interactions: development, optimization and in vitro studies. J Drug Deliv Sci Technol. 2020; :102087.
   Web of Science ®Google Scholar
• Qi F, Wu J, Fan QZ, et al. Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability. Colloids Surf B Biointerfaces. 2013;112:492–498.
   PubMed Web of Science ®Google Scholar
• He ZL, Sun Y, Wang Q, et al. Degradation and Bio-Safety evaluation of mPEG-PLGA-PLL Copolymer-Prepared nanoparticles. J Phys Chem C. 2015;119(6):3348–3362.
   Web of Science ®Google Scholar
• Chopra M, Kaur P, Bernela M, et al. Surfactant assisted nisin loaded chitosan-carageenan nanocapsule synthesis for controlling food pathogens. Food Control. 2014;37:158–164.
   Web of Science ®Google Scholar
• Zhu XM, Wu H, Yang J, et al. Antibacterial activity of chitosan grafting nisin: preparation and characterization. React Funct Polym. 2015; 91-92:71–76.
   Web of Science ®Google Scholar
• Sebak S, Mirzaei M, Malhotra M, et al. Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis. Int J Nanomedicine. 2010;5:525–532.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82(13):1107–1112.
   PubMed Web of Science ®Google Scholar
• Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112–1116.
   PubMed Web of Science ®Google Scholar
• Dheer D, Behera C, Singh D, et al. Design, synthesis and comparative analysis of triphenyl-1,2,3-triazoles as anti-proliferative agents. Eur J Med Chem. 2020;207:112813.
   PubMed Web of Science ®Google Scholar
• Shukla MK, Behera C, Chakraborty S, et al. Tumor micro-environment targeted collagenase-modified albumin nanoparticles for improved drug delivery. J Drug Deliv Sci Technol. 2022;71:103366.
   Web of Science ®Google Scholar
• Kang YH, Lee E, Choi MK, et al. Role of reactive oxygen species in the induction of apoptosis by alpha-tocopheryl succinate. Int J Cancer. 2004;112(3):385–392.
   PubMed Web of Science ®Google Scholar
• Zang Y, Beard RL, Chandraratna RA, et al. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Differ. 2001; 8(5):477–485.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–133.
   PubMed Web of Science ®Google Scholar
• Plati J, Bucur O, Khosravi-Far R. Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb). 2011;3(4):279–296.
   PubMed Web of Science ®Google Scholar
• Haider T, Pandey V, Banjare N, et al. Drug resistance in cancer: mechanisms and tackling strategies. Pharmacol Rep. 2020;72(5):1125–1151.
   PubMed Web of Science ®Google Scholar
• Vakilinezhad MA, Alipour S, Montaseri H. Fabrication and in vitro evaluation of magnetic PLGA nanoparticles as a potential methotrexate delivery system for breast cancer. J Drug Deliv Sci Technol. 2018;44:467–474.
   Web of Science ®Google Scholar
• Hamoudeh M, Al Faraj A, Canet-Soulas E, et al. Elaboration of PLLA-based superparamagnetic nanoparticles: characterization, magnetic behaviour study and in vitro relaxivity evaluation. Int J Pharm. 2007; 338(1-2):248–257.
   PubMedGoogle Scholar
• Saadati R, Dadashzadeh S. Marked effects of combined TPGS and PVA emulsifiers in the fabrication of etoposide-loaded PLGA-PEG nanoparticles: in vitro and in vivo evaluation. Int J Pharm. 2014;464(1-2):135–144.
   PubMedGoogle Scholar
• Di Francesco M, Celia C, Cristiano MC, et al. Doxorubicin hydrochloride-loaded nonionic surfactant vesicles to treat metastatic and non-metastatic breast cancer. ACS Omega. 2021; 6(4):2973–2989.
   PubMed Web of Science ®Google Scholar
• Joseph E, Singhvi G. Multifunctional nanocrystals for cancer therapy: a potential nanocarrier. In: Nanomaterials for drug delivery and therapy. Norwich (NY): William Andrew Publishing; 2019. p. 91–116.
   Google Scholar
• Di Francesco M, Celia C, Primavera R, et al. Physicochemical characterization of pH-responsive and fusogenic self-assembled non-phospholipid vesicles for a potential multiple targeting therapy. Int J Pharm. 2017; 2017/08/07/528(1-2):18–32.
   PubMedGoogle Scholar
• Zhang Y, Yang M, Portney NG, et al. Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells. Biomed Microdevices. 2008;10(2):321–328.
   PubMed Web of Science ®Google Scholar
• Das SK, Dey T, Kundu SC. Fabrication of sericin nanoparticles for controlled gene delivery. RSC Adv. 2014;4(5):2137–2142.
   Web of Science ®Google Scholar
• Sadri H, Aghaei M, Akbari V. Nisin induces apoptosis in cervical cancer cells via reactive oxygen species generation and mitochondrial membrane potential changes. Biochem Cell Biol. 2022;100(2):136–141.
   PubMedGoogle Scholar
• Karpiński TM, Adamczak A. Anticancer activity of bacterial proteins and peptides. Pharmaceutics. 2018;10(2):54.
   Web of Science ®Google Scholar
• Mohamadi N, Kazemi SM, Mohammadian M, et al. Toxicity of cisplatin-loaded poly butyl cyanoacrylate nanoparticles in a brain cancer cell line: anionic polymerization results. Asian Pac J Cancer Prev. 2017; Mar 118(3):629–632.
   PubMedGoogle Scholar
• Taebpour M, Arasteh F, Akhlaghi M, et al. Fabrication and characterization of PLGA polymeric nanoparticles containing berberine and its cytotoxicity on breast cancer cell (MCF-7). Nanomed Res J. 2021;6(4):396–408.
   Google Scholar
• Yallapu MM, Gupta BK, Jaggi M, et al. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci. 2010;351(1):19–29.
   PubMed Web of Science ®Google Scholar
• Nassir AM, Shahzad N, Ibrahim IAA, et al. Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells. Saudi Pharm J. 2018;26(6):876–885.
   PubMed Web of Science ®Google Scholar
• Lewies A, Wentzel JF, Miller HC, et al. The antimicrobial peptide nisin Z induces selective toxicity and apoptotic cell death in cultured melanoma cells. Biochimie. 2018;144:28–40.
   PubMed Web of Science ®Google Scholar
• Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis. 2003;8(2):115–128.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu C, Zhang Q, et al. Design, synthesis and biological evaluation of novel beta-pinene-based thiazole derivatives as potential anticancer agents via mitochondrial-mediated apoptosis pathway. Bioorg Chem. 2019;84:468–477.
   PubMed Web of Science ®Google Scholar
• Hetz C, Bono MR, Barros LF, et al. Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2696–701.
   PubMed Web of Science ®Google Scholar
• Fesik, S. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer. 2005;5:876–885.
   Google Scholar
• Pfeffer, CM Singh AT K. Apoptosis: A Target for Anticancer Therapy. Int J Mol Sci. 2018 Feb 2;19(2):448.
   Google Scholar
• Ahmadi S, Ghollasi M, Hosseini HM. The apoptotic impact of nisin as a potent bacteriocin on the colon cancer cells. Microb Pathog. 2017;111:193–197.
   Google Scholar